ClinicalTrials.gov
 Home    Search    Study Topics    Glossary  
 

  Full Text View  
  Tabular View  
  Contacts and Locations  
  No Study Results Posted  
  Related Studies  
A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy

This study has been completed.

Sponsors and Collaborators: Imperial College London
The Hypertension Trust
Information provided by: Imperial College London
ClinicalTrials.gov Identifier: NCT00131807
  Purpose

The purpose of this study is to explore the association between blood pressure, HIV and/or its treatment in a cross sectional observational study.


Condition Intervention
HIV Infections
Procedure: Blood Pressure Measurement
Procedure: Questionnaire

MedlinePlus related topics:   AIDS   

U.S. FDA Resources

Study Type:   Observational
Study Design:   Natural History, Cross-Sectional, Random Sample, Prospective Study
Official Title:   A Study to Explore the Association Between Blood Pressure, HIV and Antiretroviral Therapy

Further study details as provided by Imperial College London:

Estimated Enrollment:   3000
Study Start Date:   September 2005
Study Completion Date:   September 2006

Detailed Description:

Deaths from AIDS have declined dramatically since the introduction of highly active antiretroviral therapy in HIV infected patients. However the incidence of heart disease has increased four-fold and is now one of the major causes of death in HIV infected patients. While HIV drugs are known to adversely affect serum lipids, the evidence concerning the association between raised blood pressure (a major risk for cardiovascular disease) HIV and/or its treatment is limited and conflicting. The researchers believe it of interest to study heart disease risk factors in patients with HIV infection to avoid one premature cause of death (AIDS) being replaced with another potentially preventable cause of death and disability (heart disease). In this cross sectional observational study the researchers will systematically measure blood pressure and other cardiovascular risk factors in HIV positive patients on and off antiretroviral therapy. These individuals will be matched for age, sex and ethnic group with HIV negative individuals.

  Eligibility
Genders Eligible for Study:   Both
Accepts Healthy Volunteers:   Yes

Criteria

Inclusion Criteria:

  • Attending St. Mary's sexual health outpatient department
  • Patients willing to give written informed consent
  • Ability to communicate in English

Exclusion Criteria:

  • Failure to give written informed consent in English
  Contacts and Locations

Please refer to this study by its ClinicalTrials.gov identifier: NCT00131807

Locations
United Kingdom, London
St. Mary's Hospital    
      Paddington, London, United Kingdom, W2 1NY

Sponsors and Collaborators
Imperial College London
The Hypertension Trust

Investigators
Principal Investigator:     Neil R Poulter     Imperial College London    
  More Information


Study ID Numbers:   NPSW03
First Received:   August 18, 2005
Last Updated:   April 25, 2007
ClinicalTrials.gov Identifier:   NCT00131807
Health Authority:   United Kingdom: Research Ethics Committee

Keywords provided by Imperial College London:
Blood Pressure  
HIV  
Antiretroviral therapy  

Study placed in the following topic categories:
Virus Diseases
Sexually Transmitted Diseases, Viral
HIV Infections
Sexually Transmitted Diseases
Acquired Immunodeficiency Syndrome
Retroviridae Infections
Immunologic Deficiency Syndromes

Additional relevant MeSH terms:
RNA Virus Infections
Slow Virus Diseases
Immune System Diseases
Lentivirus Infections
Infection

ClinicalTrials.gov processed this record on October 03, 2008




Links to all studies - primarily for crawlers